In vitro investigation of the effects of cyclooxygenase-2 inhibitor on contractile activity of the equine dorsal and ventral colon

American Journal of Veterinary Research

Volumn 63, Issue 11, 2002, Pages 1496-1500

  Van Hoogmoed, Linda M ^a   Snyder, Jack R ^a   Harmon, Faye A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ETODOLAC; GUANETHIDINE; INDOMETACIN; NABUMETONE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL TISSUE; ARTICLE; COLON; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HORSE; IN VITRO STUDY; INTESTINE MUSCLE; MUSCLE CELL; MUSCLE STRENGTH; MUSCLE TISSUE; NONHUMAN; SMOOTH MUSCLE CONTRACTILITY;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 0036845418     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2002.63.1496     Document Type: Article

References (27)

1. MacKay RJ, French TW, Nguyen HT, et al. Effects of large doses of phenylbutazone administration to horses. Am J Vet Res 1983;44:774-780.
2. Snow DH, Bogan JA, Douglas TA, et al. Phenylbutazone toxicosis in ponies. Vet Rec 1979;105:26-30.
3. MacAllister CG, Morgan SJ, Borne AT, et al. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses. J Am Vet Med Assoc 1993;202:71-77.
4. . Schnitzer TJ. Cyclo-oxygenase-2 specific inhibitors: are they safe? Am J Med 2001;110:46S-49S.
5. Brooks PM, O'Day R. COX-2 inhibitors. Med J Aust 2000; 173:433-436.
6. Whittle BJ. COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors. Gut 2000;47:320-325.
7. Vane J, Mitchell J, Appleton I, et al. Inducible isoforms of cyclo-oxygenase and nitric oxide synthase in inflammation. Proc Natl Acad Sci U S A 1994;91:2046-2050.
8. Reuter B, Asfaha S, Buret A, et al. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase 2. J Clin Invest 1996;98:2076-2085.
9. Xie W, Chipman JG, Robertson DL, et al. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A 1991;88:2692-2696.
10. Xie W, Robertson DL, Simmons DL. Mitogen-inducible prostaglandin G/H synthase: a new target for nonsteroidal anti-inflammatory drugs. Drug Dev Res 1992;25:249-265.
11. Vane JR, Botting RM. Mechanism of action of anti-inflammatory drugs. Scand J Rheumatol 1996;25:9-21.
12. Masferrer JL, Isakson PC, Seibert K. Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract. Gastroenterol Clin North Am 1996;25:363-372.
13. Masferrer JL, Swibert K, Zweifel BS, et al. Endogenous glucocorticoids regulate an inducible cyclo-oxygenase enzyme. Proc Natl Acad Sci U S A 1992;89:3917-3921.
14. Masferrer JL, Zweifel B, Hauser S, et al. Selective inhibition of inducible cyclooxygenase-2 in vivo is anti-inflammatory and nonacrogenic. Proc Natl Acad Sci U S A 1994;91;3228-3232.
15. Shahbazian A, Schuliogoi R, Heinemann A, et al. Disturbance of peristalsis in the guinea-pig isolated small intestine by indomethacin, but not cyclo-oxygenase isoform-selective inhibitors. Br J Pharmacol 2001;132:1299-1309.
16. Campbell NB, Blikslager AT. The role of cyclo-oxygenase inhibitors in repair of ischaemic-injured jejunal mucosa in the horse. Equine Vet J Suppl 2000;32:59-64.
17. - secretion and parasite rejection in rat intestine. J Immunol 1987;138:1250-1255.
18. Maggi CA, Patacchini R, Meini S, et al. Effect of longitudinal muscle-myenteric plexus removal and indomethacin on the response to tachykinin NK-2 and NK-3 receptor agonists in the circular muscle of the guinea pig ileum. J Auton Pharmacol 1994;14:49-60.
19. 2α on contractility of taenia of the large colon of horses. Am J Vet Res 1999;60:1004-1009.
20. Van Hoogmoed LM, Snyder JR, Harmon F. In vitro investigation of the effect of prostaglandins and nonsteroidal anti-inflammatory drugs on contractile activity of the equine smooth muscle of the dorsal colon, ventral colon, and pelvic flexure. Am J Vet Res 2000;61:1259-1266.
21. Vane JR, Botting RM. Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med 1998;104:24-28.
22. Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase isozymes by aspirin and other nonsteroidal anti-inflammatory drugs. J Biol Chem 1993;268: 6610-6614.
23. Hough ME, Steel CM, Bolton JR, et al. Ulceration and stricture of the right dorsal colon after phenylbutazone administration in four horses. Aust Vet J 1999;77:285-288.
24. Meschter C, Gilbert M, Krook L, et al. The effects of phenylbutazone on the intestinal mucosa of the horse: a morphological, ultrastructural and biochemical study. Equine Vet J 1990;22:255-263.
25. Freeman DE, Inoue OJ, Eurell TE. Effects of flunixin meglumine on short circuit current in equine colonic mucosa in vitro. Am J Vet Res 1997;58:915-919.
26. Gierse JK, Hauser SD, Creely DP et al. Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem J 1995;305:479-484.
27. Kawai S. Cyclo-oxygenase selectivity and the risk of gastrointestinal complications of various non-steroidal anti-inflammatory drugs: a clinical consideration. Inflamm Res 1998;47:S102-S106.